poster
Cyclodextrins are widely used to enhance drug solubility, but their hemolytic potential presents important safety considerations for parenteral formulations. This study compares multiple cyclodextrin types across key preclinical species, providing insights to support informed formulation selection and risk mitigation.
Register to gain access to gated resources.
"*" indicates required fields
Frontage Laboratories websites use cookies. By continuing to browse the site you are agreeing to our use of cookies. For more details about cookies, and their use, please see our privacy policy.
Websites store cookies to enhance functionality and personalise your experience. You can manage your preferences, but blocking some cookies may impact site performance and services.
Essential cookies enable basic functions and are necessary for the proper function of the website.
